Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
AssigneeSmithKline Beecham Corporation
InventorsKaren Lewis, Nicola Jayne Lilliott, Donald Colin MacKenzie, Vincenzo Re
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition, which composition comprises: an insulin sensitiser and another antidiabetic agent and a pharmaceutically acceptable carrier therefor, wherein the composition is arranged to provide a modified release of at least one of the insulin sensitiser and the other antidiabetes agent, and the use of such composition in medicine.
Claims18
A pharmaceutical composition, which composition comprises:
- an insulin sensitiser and another antidiabetic agent and a pharmaceutically acceptable carrier therefor, wherein the composition is arranged to provide a modified release of at least one of the insulin sensitiser and the other antidiabetic agent.
A modified release pharmaceutical composition, which composition comprises:
- an insulin sensitiser, such as Compound (I), and another antidiabetic agent and a pharmaceutically acceptable carrier therefor, wherein the carrier is arranged to provide a modified release of at least one of the insulin sensitiser and the other antidiabetes agent.
A composition according to claim 7, wherein the enteric coated tablet is a multi-layer tablet.
Dependencies are inferred from the claim text.